PubMed:32514935 / 0-166 JSONTXT

{"project":"LitCovid-OGER-BB","denotations":[{"id":"T1","span":{"begin":39,"end":47},"obj":"SP_7"},{"id":"T2","span":{"begin":94,"end":104},"obj":"CHEBI:35222"},{"id":"T3","span":{"begin":94,"end":104},"obj":"CHEBI:35222"},{"id":"T4","span":{"begin":117,"end":131},"obj":"DG_37"}],"namespaces":[{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"}],"text":"Renin-angiotensin system inhibition in COVID-19 patients.\nAngiotensin-converting enzyme (ACE) inhibitors (ACEIs) and angiotensin II type‑1 receptor blockers (ARBs) ar"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T1","span":{"begin":0,"end":24},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"uberon_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/UBERON_0018229"}],"text":"Renin-angiotensin system inhibition in COVID-19 patients.\nAngiotensin-converting enzyme (ACE) inhibitors (ACEIs) and angiotensin II type‑1 receptor blockers (ARBs) ar"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T1","span":{"begin":39,"end":47},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Renin-angiotensin system inhibition in COVID-19 patients.\nAngiotensin-converting enzyme (ACE) inhibitors (ACEIs) and angiotensin II type‑1 receptor blockers (ARBs) ar"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T1","span":{"begin":6,"end":17},"obj":"Chemical"},{"id":"T2","span":{"begin":58,"end":69},"obj":"Chemical"},{"id":"T3","span":{"begin":94,"end":104},"obj":"Chemical"},{"id":"T4","span":{"begin":117,"end":131},"obj":"Chemical"},{"id":"T7","span":{"begin":117,"end":128},"obj":"Chemical"},{"id":"T8","span":{"begin":129,"end":131},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_48433"},{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_2719"},{"id":"A3","pred":"chebi_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_35222"},{"id":"A4","pred":"chebi_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_2719"},{"id":"A5","pred":"chebi_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_48432"},{"id":"A6","pred":"chebi_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_58506"},{"id":"A7","pred":"chebi_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_48433"},{"id":"A8","pred":"chebi_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/CHEBI_74067"}],"text":"Renin-angiotensin system inhibition in COVID-19 patients.\nAngiotensin-converting enzyme (ACE) inhibitors (ACEIs) and angiotensin II type‑1 receptor blockers (ARBs) ar"}

{"project":"LitCovid-sentences","denotations":[{"id":"T1","span":{"begin":0,"end":57},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Renin-angiotensin system inhibition in COVID-19 patients.\nAngiotensin-converting enzyme (ACE) inhibitors (ACEIs) and angiotensin II type‑1 receptor blockers (ARBs) ar"}